The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats
- 1 August 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 184 (1) , 75-85
- https://doi.org/10.1016/0014-2999(90)90668-v
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Quipazine reduces food intake in the rat by activation of 5-HT2-receptorsBritish Journal of Pharmacology, 1988
- Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerveBritish Journal of Pharmacology, 1987
- Pharmacological evidence that the sympathetic nervous system mediates the increase in secretion of renin produced by p-chloroamphetamineNeuropharmacology, 1984
- Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5‐hydroxytiyptamineBritish Journal of Pharmacology, 1984
- Mechanism of the Hypotensive Effect of KetanserinJournal of Cardiovascular Pharmacology, 1982
- Evidence that the Mediobasal Hypothalamus is Involved in Serotonergic Stimulation of Renin SecretionNeuroendocrinology, 1982
- The Effect of Quipazine, A Serotonin Receptor Agonist, on Serum Corticosterone Concentration in RatsEndocrine Research Communications, 1978
- The effects of quipazine on 5-HT metabolism in the rat brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976
- The effects of quipazine on serotonin metabolism in rat brainLife Sciences, 1976
- Similarities between the pharmacological actions of quipazine and serotoninEuropean Journal of Pharmacology, 1969